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P U B L I S H E D B Y E L S E V I E R I N C .LettersDirect Catheter-Based
Thrombectomy for
Acute Ischemic Stroke
Outcomes of Consecutive Patients Treated
in Interventional Cardiology Centers
in Close Cooperation With NeurologistsWe sought to evaluate the outcomes of acute stroke
patients, who did not undergo thrombolysis, and who
were treated by direct catheter-based thrombectomy
(CBT) in 3 interventional cardiology centers without
pre-existing onsite programs for neurovascular in-
terventions. Neurologists routinely selected patients
for intervention. Their selection was on the basis of
clinical presentation and computed tomography (CT)
imaging. The decision not to use thrombolysis was on
the basis of the presence of a contraindication or on a
predicted short CT-to-sheath insertion time.
We analyzed the data of 84 consecutive patients
with acute ischemic stroke (National Institutes of
Health Stroke Score [NIHSS] $6) who were treated in
these 3 centers with mechanical thrombectomy
without bridging or intra-arterial use of ﬁbrinolytics
between January 2012 and November 2014. The local
ethical committees of the participating institutions
approved the study.
Good neurological outcome was deﬁned as a
modiﬁed Rankin scale (mRS) #2 after 3 months.
Symptomatic intracranial hemorrhage was deﬁned as
intracranial bleeding on CT or magnetic resonance
(MR) imaging with neurological deterioration of $4
NIHSS grades within 7 days. Time points were deﬁned
as follows: stroke onset as the time the patient was
last seen well; CT (MR) as time of initiation of CT (MR)
imaging; arterial puncture as time of sheath insertion;
and recanalization as time of ﬁrst-documented
Thrombolysis In Cerebral Infarction [TICI] $2a ﬂow
in the respective artery. Baseline clinical character-
istics of the patients are listed in Table 1.
The middle cerebral artery (MCA) was occluded
alone in 46 patients; a combined internal carotid ar-
tery (ICA) lesion and MCA occlusion was found in 27
patients. The ICA was occluded alone in 9 patients,
the vertebral artery was occluded in 1 patient, and thebasilar artery was occluded in 1 patient. We used the
following stent retriever types: Solitaire (Covidien
ev3) 41 times; Trevo (Stryker Neurovascular) 27 times;
Catch (Balt Extrusion) 6 times; Penumbra (Penumbra)
4 times; BONnet (Phenox) 3 times; Eric (Terumo) 2
times; and pREset (Phenox) 2 times. Simultaneous
carotid stenting was performed in 12 patients: Xact
stent (Abbott Vascular) 8 times, Wallstent (Boston
Scientiﬁc) 3 times, Adapt stent (Boston Scientiﬁc)
1 time. The median time intervals are shown in
Table 1.
Angiographic success, which was deﬁned as TICI
$2a ﬂow at the end of the procedure, was achieved in
74% of patients. Immediate neurological impro-
vement occurred in 25 patients (30%), and 6 reached
complete neurological recovery (mRS ¼ 0). Twenty-
four patients (29%) were discharged directly home
(no institutional rehabilitation). Good neurological
outcome was achieved in 42% (35 of 84) of patients.
The strongest predictor of good outcome was the time
from stroke onset to an arterial puncture of <180 min;
patients treated within 3 h from stroke onset had a
good outcome in 54%, whereas patients treated after
3 h had a good outcome in only 31% (p ¼ 0.031).
Recently, 3 randomized trials (1–3) demonstrated
the beneﬁts of timely mechanical intervention in
acute stroke. Future guidelines certainly will reﬂect
these data.
The main observations of this analysis are: 1) acute
stroke interventions performed by interventional
cardiologists may achieve results comparable to those
of neurointerventional centers (e.g., compared with
data in the MR CLEAN (Multicenter Randomized
CLinical trial of Endovascular treatment for Acute
ischemic stroke in the Netherlands) investigation (1);
and 2) direct CBT performed without thrombolytics
quickly after CT imaging may be a viable alternative
to bridging thrombolysis (facilitated CBT) (1,2).
Cardiology centers are able to achieve short CT to
catheter laboratory times, due to their experience
with primary angioplasty services for acute myocar-
dial infarction. The ﬁrst 5 cases of acute stroke
treatment by interventional cardiologists were pub-
lished in 2008 (4).
It is not certain whether available neuroradiology
services will be able to meet the expanding needs
of the population (facing the fact, that CBT becomes
TABLE 1 Baseline Characteristics, Time Delays, and Outcomes
Baseline clinical characteristics
Female 37 (44)
Anterior stroke 82 (97)
Age, yrs 64.8  13.8
Diabetes mellitus 25 (30)
History of hypertension 63 (75)
Clinical evidence of atherosclerosis 37 (44)
Atrial ﬁbrillation (any type, any time) 34 (40)
History of stroke or TIA 9 (11)
Admission NIHSS 18.0  4.1 (median 18, range 6–27)
Time delays: median values, min (IQR: 25–75)
Stroke onset to CT 90 (55–145)
CT to sheath insertion 64 (24–89)
Sheath insertion to recanalization 53 (41–70)
Stroke onset to sheath insertion 165 (95–260)
Stroke onset to recanalization 236 (202–342)
Procedural data
Intubation/general anesthesia use 24 (29)
Heparin dose, units 3,570  3,800 (median 2500)
Angiographic and clinical outcomes
Recanalization rate (TICI 2a/2b/3 ﬂow) 62 (74)
Good neurological outcome at 90 days (mRS #2) 35 (42)
90-day mRS among early presenters
(stroke onset to sheath insertion time <3 h)
3.15  2.20 (median 2)*
90-day mRS among late presenters
(stroke onset to sheath insertion time >3 h)
3.81  2.11 (median 4)*
90-day mortality 27 (32)
Symptomatic intracranial hemorrhage at 7 days (%) 12 (14)
Values are n (%) or mean  SD, unless otherwise noted. *p ¼ 0.160.
CT ¼ computed tomography; IQR ¼ interquartile range; mRS ¼ modiﬁed Rankin scale; NIHSS ¼ National
Institutes of Health Stroke Score; TIA ¼ transient ischemic attack; TICI ¼ Thrombolysis In Cerebral Infarction.
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488class IA indication). In contrast, interventional car-
diology services for acute myocardial infarction are
available on a 24/7 basis in almost all European and
North American countries, and are becoming more
available on other continents. Thus, in places where
neuroradiology services are not available, the in-
volvement of interventional cardiologists may be a
reasonable option.
Direct mechanical thrombectomy performed by a
cardiologist may be considered a treatment option for
acute stroke in centers where no neurointerventional
services exist. Cardiology centers are able to achieve
short CT to catheter laboratory times due to their
experience in primary angioplasty for acute myocar-
dial infarction. Outcomes are comparable to endo-
vascular interventions performed in neuroradiology
centers.*Petr Widimsky, MD, DrSc
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204–7.Net Clinical Beneﬁt for
Oral Anticoagulation,
Aspirin, or No Therapy
in Nonvalvular Atrial
Fibrillation Patients With
1 Additional Risk Factor of
the CHA2DS2-VASc Score
(Beyond Sex)Whether to anticoagulate patients with atrial
ﬁbrillation (AF) and 1 stroke risk factor (i.e., CHA2DS2-
VASc [congestive heart failure, hypertension, age
